Marzouki Hani Z, Abdalwassie Lujain K, Tallab Mawaddah A, Al-Khatib Talal, Safdar Osama Y, Alzharani Fatma, Alsiny Fayza, Farsi Nada J
Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, , King Abdulaziz University, Jeddah, 21441 Saudi Arabia.
Department of Dermatology, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.
Indian J Otolaryngol Head Neck Surg. 2022 Dec;74(Suppl 3):5499-5505. doi: 10.1007/s12070-021-02696-5. Epub 2021 Aug 22.
Sickle cell disease (SCD) typically manifests in early childhood as attacks of pain known as vaso-occlusive crises. Infection and hypoxemia have been linked with these recurrent episodes and with prolonged hospitalization in SCD patients. However, adenoids and tonsils as sources of infection and causes of hypoxemia have not been adequately investigated in association with vaso-occlusive crises in SCD. To assess the association between adenotonsillectomy and frequency of vaso-occlusive crisis in SCD patients who underwent this procedure at our Hospital, and between adenotonsillectomy and frequency of blood transfusions and emergency department and intensive care unit admissions. We used medical record data to conduct a retrospective review of SCD patients who underwent adenoidectomy and/or tonsillectomy between 2005 and 2017. Eligible subjects were assessed for frequency of vaso-occlusive crises, blood transfusions, and emergency department and intensive care unit admissions. Using the Wilcoxon signed rank test, we compared the frequencies of each outcome preoperatively and 1, 3, 5, and 10 years postoperatively. Of 524 records reviewed, 40 eligible patients were included in the study. Minimal reduction was observed in the frequency of vaso-occlusive crisis episodes within 1 and 3 years after adenotonsillectomy ( = 0.337 and = 0.549, respectively). Although the 5- and 10-year postoperative vaso-occlusive crisis frequency tended to be higher than that in the preoperative period, none of the results reached statistical significance. The number of emergency department admissions showed a statistically significant increase 3 years postoperatively compared with that in the preoperative period ( = 0.043). There were no statistically significant differences in perioperative blood transfusion frequency or number of intensive care unit admissions in any period. Adenotonsillectomy in SCD patients does not seem to be related to the frequency of vaso-occlusive crises, blood transfusions, or emergency department or intensive care unit admissions. Prospective studies with larger sample sizes are recommended to further evaluate these findings.
镰状细胞病(SCD)通常在儿童早期表现为疼痛发作,即血管闭塞性危机。感染和低氧血症与这些复发事件以及SCD患者的长期住院有关。然而,腺样体和扁桃体作为感染源和低氧血症的原因,尚未与SCD中的血管闭塞性危机相关联进行充分研究。为了评估腺样体扁桃体切除术与我院接受该手术的SCD患者血管闭塞性危机发生频率之间的关联,以及腺样体扁桃体切除术与输血频率、急诊科和重症监护病房入院次数之间的关联。我们使用病历数据对2005年至2017年间接受腺样体切除术和/或扁桃体切除术的SCD患者进行了回顾性研究。对符合条件的受试者评估血管闭塞性危机、输血以及急诊科和重症监护病房入院的频率。使用Wilcoxon符号秩检验,我们比较了术前以及术后1、3、5和10年各结果的频率。在审查的524份记录中,40名符合条件的患者被纳入研究。腺样体扁桃体切除术后1年和3年内,血管闭塞性危机发作频率观察到最小程度的降低(分别为=0.337和=0.549)。尽管术后5年和10年的血管闭塞性危机频率往往高于术前,但没有结果达到统计学显著性。与术前相比,术后3年急诊科入院次数显示出统计学显著性增加(=0.043)。围手术期输血频率或任何时期重症监护病房入院次数均无统计学显著性差异。SCD患者的腺样体扁桃体切除术似乎与血管闭塞性危机、输血、急诊科或重症监护病房入院频率无关。建议进行更大样本量的前瞻性研究以进一步评估这些发现。